<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00414752</url>
  </required_header>
  <id_info>
    <org_study_id>CAFQ056A2109</org_study_id>
    <nct_id>NCT00414752</nct_id>
  </id_info>
  <brief_title>Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking</brief_title>
  <official_title>A Randomized, Double Blind, Multiple Dose, Cross-Over, Placebo- and Active-Controlled Proof of Concept Study to Explore the Effects of AFQ056 and Nicotine (Active Comparator) on Craving and Withdrawal During Voluntary Smoking Abstinence in Healthy Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and efficacy of AFQ056 and nicotine
      compared to placebo on craving and withdrawal symptoms during voluntary smoking stoppage in
      healthy smokers. This study will also assess how the body interacts with AFQ056.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of craving by self-report questionnaires during 3 days of voluntary smoking stoppage</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in symptoms of withdrawal during 3 days of voluntary smoking stoppage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in nicotine consumption during 6 days of free smoking</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in impulsivity during 3 days of free smoking and during 3 days of voluntary smoking stoppage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in craving during 6 days of free smoking</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability of AFQ056 during treatment periods</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of how the body interacts with AFQ056</measure>
  </secondary_outcome>
  <enrollment>36</enrollment>
  <condition>Smoking Abstinence</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AFQ065</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, male &amp; female subjects at least 18 years and ≤60 years of age

          -  In good health

          -  Female subjects must be surgically sterilized or postmenopausal.

          -  Current smokers not intending to quit

          -  Smoke on average 15 cigarettes or more and less than 60 cigarettes a day for the past
             year

          -  Fagerström Test for Nicotine Dependence score of at least 5 (indicates moderate to
             heavy smokers)

          -  Willing to refrain from smoking as required

          -  Written informed consent before entering the study

        Exclusion Criteria:

          -  History of heart disease, septum defect and/or cardiac valves surgery; clinical
             relevant abnormality in the ECG

          -  Investigational drug treatment within 4 weeks prior to screening unless local health
             authority guidelines mandate a longer period

          -  Women of childbearing potential, pregnant or lactating females

          -  Donation of one unit (400mL) or more of blood, significant blood loss equaling at
             least one unit of blood within the past 2 months or a blood transfusion within 8 weeks
             prior to screening.

          -  Coffee consumption of more than 6 cups coffee/day

          -  Use of a medication within 2 weeks prior to Day 1 of each treatment period

        Other protocol-defined inclusion/exclusion criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Investigator site</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nuernberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2006</study_first_submitted>
  <study_first_submitted_qc>December 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2006</study_first_posted>
  <last_update_submitted>June 21, 2007</last_update_submitted>
  <last_update_submitted_qc>June 21, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2007</last_update_posted>
  <keyword>Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

